info@seagull-health.com
SeagullHealth
search
Raloxifene(Evista)
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.
Evista(Raloxifene) Instructions:Uses,Dosage, Side Effects
EVISTA, with the generic name Raloxifene Hydrochloride, is an oral tablet classified as a Selective Estrogen Receptor Modulator (SERM). Its primary active component is raloxifene hydrochloride, with each film-coated tablet containing 60 mg. The drug functions as an estrogen agonist in bone tissue and an antagonist in uterine and breast tissues. It is specifically approved for use in postmenopausal women and is supplied as white, elliptical tablets.
Treatment and prevention of osteoporosis in postmenopausal women.
Reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis.
Reduction of the risk of invasive breast cancer in postmenopausal women identified as being at high risk for invasive breast cancer.
Important Limitations: Not indicated for treatment of invasive breast cancer, reduction of breast cancer recurrence risk, or reduction of noninvasive breast cancer risk.
The recommended dosage is one 60 mg tablet taken orally once daily.
Administration can occur at any time of day, with or without food.
For invasive breast cancer risk reduction, the optimal treatment duration is not definitively established.
Patients should receive supplemental calcium and vitamin D if their daily dietary intake is insufficient.
- Core products
- Antitumor drugs
- General drug
- Antiviral drugs
- Biological agents
- mailbox：info@lucius.la
